20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
Go back to 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies| (NASDAQ: AIDX) | Delayed: 0.56 -0.04 (6.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $ | |||
| Open | $0.57 | 52 Week Low | $ | |||
| Day High | $0.58 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $ | |||
| Volume | 54,856 | |||||
| (NASDAQ: AIDX) | Delayed: 0.56 -0.04 (6.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $ | |||
| Open | $0.57 | 52 Week Low | $ | |||
| Day High | $0.58 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $ | |||
| Volume | 54,856 | |||||

